Albany Regional Cancer Center

Albany, New York 12208

0 studies enrolling now · 12 studies all time

What they study most

Breast Cancer, Carcinoma, Renal Cell, Chronic Lymphocytic Leukemia, Colorectal Cancer, Hodgkin's Lymphoma, Hormone Refractory Prostate Cancer, Lymphoma, Non-Hodgkin, Metastatic Androgen Independent Prostate Cancer, Non-Small Cell Lung Cancer, Prostate Cancer

Studies at this site

• Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) — Completed
• Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer — Completed
• Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer — Completed
• Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective. — Withdrawn before enrolling
• Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer — Completed
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed
• Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia — Completed
• Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy — Completed
• Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
• A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer — Completed
• Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma — Completed
• Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma — Completed